Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1

Interventions

pembrolizumab 130 Carboplatin 106 Paclitaxel 65 Cisplatin 61 Gemcitabine 59 Pemetrexed 57 Bevacizumab 54 Docetaxel 49 Fluorouracil 43 Oxaliplatin 41 atezolizumab 37 Dexamethasone 36 Leucovorin 34 Cetuximab 33 130-nm albumin-bound paclitaxel 33 Nivolumab 30 Cyclophosphamide 30 Prednisone 29 Rituximab 28 Capecitabine 28 durvalumab 27 Fulvestrant 24 Lenalidomide 22 enzalutamide 21 Letrozole 21 Irinotecan 21 venetoclax 20 Doxorubicin 19 ribociclib 18 pomalidomide 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Whole Genome Sequencing × 30 days × Clear all

NCT04597710 2026-05-29

Precision1

Perspectum

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡